These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9618773)

  • 1. Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations.
    Longini IM; Sagatelian K; Rida WN; Halloran ME
    Stat Med; 1998 May; 17(10):1121-36. PubMed ID: 9618773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the effect of HIV vaccination on infectiousness.
    Rida WN
    Stat Med; 1996 Nov 15-30; 15(21-22):2393-404; discussion 2405-12. PubMed ID: 8931209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study designs for evaluating different efficacy and effectiveness aspects of vaccines.
    Halloran ME; Struchiner CJ; Longini IM
    Am J Epidemiol; 1997 Nov; 146(10):789-803. PubMed ID: 9384199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmented HIV vaccine trial design for estimating reduction in infectiousness and protective efficacy.
    Datta S; Halloran ME; Longini IM
    Stat Med; 1998 Jan; 17(2):185-200. PubMed ID: 9483728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field study on the use of vaccination to control the occurrence of lumpy skin disease in Ethiopian cattle.
    Molla W; Frankena K; Gari G; de Jong MCM
    Prev Vet Med; 2017 Nov; 147():34-41. PubMed ID: 29254724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of Mycobacterium bovis transmission in a badger vaccine field trial.
    Aznar I; Frankena K; More SJ; O'Keeffe J; McGrath G; de Jong MCM
    Prev Vet Med; 2018 Jan; 149():29-37. PubMed ID: 29290298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measures of the effects of vaccination in a randomly mixing population.
    Haber M; Longini IM; Halloran ME
    Int J Epidemiol; 1991 Mar; 20(1):300-10. PubMed ID: 2066239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccines.
    Longini IM; Datta S; Halloran ME
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec; 13(5):440-7. PubMed ID: 8970471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On vaccine efficacy and reproduction numbers.
    Farrington CP
    Math Biosci; 2003 Sep; 185(1):89-109. PubMed ID: 12900143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causal inference for vaccine effects on infectiousness.
    Halloran ME; Hudgens MG
    Int J Biostat; 2012 Jan; 8(2):. PubMed ID: 22499732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semi-parametric models for mismeasured exposure information in vaccine trials.
    Golm GT; Halloran ME; Longini IM
    Stat Med; 1998 Oct; 17(20):2335-52. PubMed ID: 9819831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using validation sets for outcomes and exposure to infection in vaccine field studies.
    Halloran ME; Longini IM
    Am J Epidemiol; 2001 Sep; 154(5):391-8. PubMed ID: 11532779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficiency of estimating vaccine efficacy for susceptibility and infectiousness: randomization by individual versus household.
    Datta S; Halloran ME; Longini IM
    Biometrics; 1999 Sep; 55(3):792-8. PubMed ID: 11315008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of effectiveness of a vaccination program against an infectious disease at the population level.
    Carpenter TE
    Am J Vet Res; 2001 Feb; 62(2):202-5. PubMed ID: 11212028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating vaccine efficacy from household data observed over time.
    Davis XM; Haber M
    Stat Med; 2004 Oct; 23(19):2961-74. PubMed ID: 15351955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure efficacy and change in contact rates in evaluating prophylactic HIV vaccines in the field.
    Halloran ME; Longini IM; Haber MJ; Struchiner CJ; Brunet RC
    Stat Med; 1994 Feb; 13(4):357-77. PubMed ID: 8177986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial design to estimate the effect of vaccination on tuberculosis incidence in badgers.
    Aznar I; McGrath G; Murphy D; Corner LA; Gormley E; Frankena K; More SJ; Martin W; O'Keeffe J; De Jong MC
    Vet Microbiol; 2011 Jul; 151(1-2):104-11. PubMed ID: 21450420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A structured avian influenza model with imperfect vaccination and vaccine-induced asymptomatic infection.
    Gulbudak H; Martcheva M
    Bull Math Biol; 2014 Oct; 76(10):2389-425. PubMed ID: 25230802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine impact in homogeneous and age-structured models.
    Magpantay FMG
    J Math Biol; 2017 Dec; 75(6-7):1591-1617. PubMed ID: 28417166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal prophylactic vaccination in segregated populations: When can we improve on the equalising strategy?
    Keeling MJ; Ross JV
    Epidemics; 2015 Jun; 11():7-13. PubMed ID: 25979277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.